Questions? 800.667.7745; Voice Mail: 925-391-0363
Email: [email protected]
Add To Cart

Section 9
Advance care planning: preferences for care at the end of life

Answer Booklet | Table of Contents | Printable Page

The Publication below is from Agency for Healthcare Research and Quality. 

Hint:
1. Use + and – at top of page to increase or decrease size
2. Click and drag on page to move text to be more visible , if needed
3. Click speaker at top of page to add or delete sound
4. If message below indicates "A plugin is needed to display this content." CLICK HERE
Questions? Email: [email protected]

- Kass-Bartelmes BL, Hughes R, Rutherford MK. Advance care planning: preferences for care at the end of life. Rockville (MD): Agency for Healthcare Research and Quality; 2003. Research in Action Issue #12. AHRQ Pub No. 03-0018, p1-20.
The article above contains foundational information. Articles below contain optional updates.


Answer Booklet for this course
Forward to Section 10
Back to Section 8
Table of Contents
Top


The article above contains foundational information. Articles below contain optional updates.
More Articles on 50+ topics
Neurological diseases cost the US Nearly $800 billion per year - March 28, 2017
A new article reports the most common neurological diseases pose a serious annual financial burden for the nation.
Scientists achieve research milestone with Parkinson's disease - March 27, 2017
In a Phase I clinical study, researchers were able to transform the immune system by taking cells damaged in Parkinson’s disease and making them cells that protect and defend against brain injury.
Concern over high US prescribing levels of common drug linked to dementia - March 27, 2017
A new analysis raises concern over high prescription rates in the USA of a common drug used to treat overactive bladder. The drug, oxybutynin, when taken orally, is consistently linked with cognitive impairment and dementia in the elderly. The analysis shows that oxybutynin, is prescribed in more than a quarter of cases of overactive bladder (27.3%), even though other more suitable drugs are available.
Alzheimer's disease: On the hunt for the biomarker signal for early detection - March 27, 2017
Around 100,000 Austrians suffer from Alzheimer's disease and 16,000 from Parkinson's. Experts estimate that, in view of the ageing population, these numbers are set to triple over the next 30 years. Both Alzheimer's and Parkinson's diseases are progressive degenerative diseases of the brain, which start up to 30 years before the onset of symptoms. Early diagnosis would be a huge help in combating the disease. However, the early detection tests that are available do not provide any reliable prediction about the further course of the disease and also carry the risk of producing a false positive result.
Exercising 2.5 hours per week associated with slower declines in Parkinson's disease patients - March 23, 2017
Parkinson's disease (PD) is a progressive condition that often results in mobility impairments and can lead to decreased health-related quality of life (HRQL) and death. There is evidence that physical activity can delay decline in PD patients. Researchers determined that that people who exercised regularly had significantly slower declines in HRQL and mobility over a two-year period.